サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442896

ペットケア糖尿病薬市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年

Pet Care Diabetes Drugs Market (Product Type: Insulin Drugs, SGLT2 Inhibitors, and Others; and Animal Type: Cats and Dogs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
ペットケア糖尿病薬市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年
出版日: 2024年01月18日
発行: Transparency Market Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ペットケア糖尿病薬市場 - レポートの範囲

アルツハイマー病に関連する世界の認知症市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の認知症市場の収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間のアルツハイマー病市場に関連付けられています。レポートは、2023年から2031年までの世界のアルツハイマー病に関連する認知症市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、アルツハイマー病市場に関連する認知症を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、アルツハイマー病に関連する世界の認知症市場の競合情勢を詳しく掘り下げています。アルツハイマー病に関連する世界の認知症市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで概説されているアルツハイマー病に関連する世界の認知症市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 重要な洞察

  • ペットの糖尿病の疫学
  • 主要な業界イベント
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：動物の種類別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 動物タイプ別の市場金額予測、2017年～2031年
    • 猫
    • 犬
  • 動物タイプ別の市場の魅力

第7章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 製品タイプ別の市場金額予測、2017年～2031年
    • インスリン薬
    • SGLT2阻害剤
    • その他
  • 製品タイプ別の市場魅力度

第8章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • エンドユーザー別の市場金額予測、2017年～2031年
    • 獣医病院の薬局
    • 小売薬局
    • その他
  • エンドユーザー別の市場の魅力度

第9章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 地域別の市場金額予測
    • 北米
    • 欧州
    • 世界のその他の地域
  • 国・地域別の市場魅力度

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 その他の世界の市場分析と予測

第13章 競合情勢

  • 市場企業-競合マトリックス（企業の階層および規模別）
  • 企業別市場シェア分析（2022年）
  • 企業プロファイル
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Merck Animal Health
図表

List of Tables

  • Table 01: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 02: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 03: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 07: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 11: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 14: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Pet Care Diabetes Drugs Market Size, by Animal Type, 2022
  • Figure 02: Global Pet Care Diabetes Drugs Market share (%), by Animal Type, 2022
  • Figure 03: Global Pet Care Diabetes Drugs Market Size, by Product Type, 2022
  • Figure 04: Global Pet Care Diabetes Drugs Market share (%), by Product Type, 2022
  • Figure 05: Global Pet Care Diabetes Drugs Market Size, by End-user, 2022
  • Figure 06: Global Pet Care Diabetes Drugs Market share (%), by End-user, 2022
  • Figure 07: Global Pet Care Diabetes Drugs Market, by Region (2022 and 2031)
  • Figure 08: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 10: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022
  • Figure 11: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2031
  • Figure 12: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 13: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 14: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022
  • Figure 15: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2031
  • Figure 16: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 17: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 18: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 19: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 20: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 21: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
  • Figure 22: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 23: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 24: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 26: North America Pet Care Diabetes Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 29: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 30: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 31: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-31
  • Figure 32: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 33: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: Europe Pet Care Diabetes Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 36: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 37: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 38: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 39: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 40: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 41: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 43: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 45: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 46: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 47: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 48: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 49: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL85929

Pet Care Diabetes Drugs Market - Scope of Report

TMR's report on the global dementia associated with Alzheimer's disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global dementia associated with Alzheimer's disease market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dementia associated with Alzheimer's disease market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dementia associated with Alzheimer's disease market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dementia associated with Alzheimer's disease market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global dementia associated with Alzheimer's disease market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dementia associated with Alzheimer's disease market.

The report delves into the competitive landscape of the global dementia associated with Alzheimer's disease market. Key players operating in the global dementia associated with Alzheimer's disease market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dementia associated with Alzheimer's disease market profiled in this report.

Key Questions Answered in Global dementia associated with Alzheimer's disease Market Report:

  • What is the sales/revenue generated by dementia associated with Alzheimer's disease across all regions during the forecast period?
  • What are the opportunities in the global dementia associated with Alzheimer's disease market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Pet Care Diabetes Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global dementia associated with Alzheimer's disease market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dementia associated with Alzheimer's disease market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dementia associated with Alzheimer's disease market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pet Care Diabetes Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Epidemiology of Diabetes in Pets
  • 5.2. Key Industry Events
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Animal Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Animal Type, 2017 - 2031
    • 6.3.1. Cats
    • 6.3.2. Dogs
  • 6.4. Market Attractiveness By Animal Type

7. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Product Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Product Type, 2017 - 2031
    • 7.3.1. Insulin Drugs
    • 7.3.2. SGLT2 Inhibitors
    • 7.3.3. Others
  • 7.4. Market Attractiveness By Product Type

8. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2017 - 2031
    • 8.3.1. Vet Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Rest of World
  • 9.3. Market Attractiveness By Country/Region

10. North America Pet Care Diabetes Drugs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 10.2.1. Cats
    • 10.2.2. Dogs
  • 10.3. Market Value Forecast By Product Type, 2017 - 2031
    • 10.3.1. Insulin Drugs
    • 10.3.2. SGLT2 Inhibitors
    • 10.3.3. Others
  • 10.4. Market Value Forecast By End-user, 2017 - 2031
    • 10.4.1. Vet Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2017 - 2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Animal Type
    • 10.6.2. By Product Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pet Care Diabetes Drugs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 11.2.1. Cats
    • 11.2.2. Dogs
  • 11.3. Market Value Forecast By Product Type, 2017 - 2031
    • 11.3.1. Insulin Drugs
    • 11.3.2. SGLT2 Inhibitors
    • 11.3.3. Others
  • 11.4. Market Value Forecast By End-user, 2017 - 2031
    • 11.4.1. Vet Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country, 2017 - 2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Animal Type
    • 11.6.2. By Product Type
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Rest of World Pet Care Diabetes Drugs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 12.2.1. Cats
    • 12.2.2. Dogs
  • 12.3. Market Value Forecast By Product Type, 2017 - 2031
    • 12.3.1. Insulin Drugs
    • 12.3.2. SGLT2 Inhibitors
    • 12.3.3. Others
  • 12.4. Market Value Forecast By End-user, 2017 - 2031
    • 12.4.1. Vet Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Others
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Animal Type
    • 12.5.2. By Product Type
    • 12.5.3. By End-user

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 13.2. Market Share Analysis By Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Boehringer Ingelheim International GmbH
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Elanco
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. SWOT Analysis
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Merck Animal Health
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. SWOT Analysis
      • 13.3.3.5. Strategic Overview